C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/22 (2006.01) A61K 31/499 (2006.01) A61P 7/02 (2006.01) A61P 9/10 (2006.01) A61P 43/00 (2006.01)
Patent
CA 2651420
Disclosed is an anti-coagulant which has extremely excellent inhibitory effect on FXa and an extremely poor inhibitory effect on hERG channel, and can be administered through the oral route. Specifically, disclosed is a compound represented by the formula (I) or a pharmaceutically acceptable salt thereof.
L'invention concerne un anticoagulant ayant un effet inhibiteur de FXa particulièrement excellent et un effet inhibiteur du canal hERG particulièrement faible, ledit anticoagulant pouvant être administré par voie orale. L'invention concerne plus spécifiquement un composé répondant à la formule (I) ou l'un de ses sels acceptable sur le plan pharmaceutique.
Nishida Hidemitsu
Sawama Yuka
Mochida Pharmaceutical Co. Ltd.
Smart & Biggar
LandOfFree
Spiro tetracyclic compound does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Spiro tetracyclic compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spiro tetracyclic compound will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1714110